Equaline Heartburn Relief Interactions
There are 141 drugs known to interact with Equaline Heartburn Relief (ranitidine), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 12 are major, 68 are moderate, and 61 are minor.
- View all 141 medications that may interact with Equaline Heartburn Relief
- View Equaline Heartburn Relief alcohol/food interactions (1)
- View Equaline Heartburn Relief disease interactions (6)
Most frequently checked interactions
View interaction reports for Equaline Heartburn Relief (ranitidine) and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- amoxicillin
- ashwaganda
- aspirin
- Cheratussin AC (codeine / guaifenesin)
- Claritin (loratadine)
- Concept DHA (multivitamin, prenatal)
- CoQ10 (ubiquinone)
- Cortef (hydrocortisone)
- dexfenfluramine
- diclofenac
- EPA Fish Oil (omega-3 polyunsaturated fatty acids)
- famotidine
- Flector Patch (diclofenac topical)
- Flexeril (cyclobenzaprine)
- gabapentin
- ginseng
- ibuprofen
- Intuniv (guanfacine)
- lamotrigine
- lansoprazole
- methocarbamol
- milk thistle
- Morphine Sulfate SR (morphine)
- naltrexone
- Omega-3 (omega-3 polyunsaturated fatty acids)
- omega-3 polyunsaturated fatty acids
- Omega-500 (omega-3 polyunsaturated fatty acids)
- oxycodone
- Percocet 5 / 325 (acetaminophen / oxycodone)
Equaline Heartburn Relief alcohol/food interactions
There is 1 alcohol/food interaction with Equaline Heartburn Relief (ranitidine).
Equaline Heartburn Relief disease interactions
There are 6 disease interactions with Equaline Heartburn Relief (ranitidine) which include:
More about Equaline Heartburn Relief (ranitidine)
- Compare alternatives
- Latest FDA alerts (18)
- Side effects
- Dosage information
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.